| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |